HIV-associated nephropathy: a brief review

Area of Science:

• Nephrology
• Virology
• Immunology

Background:

• HIV-associated nephropathy (HIVAN) is a significant cause of renal failure in HIV-1 positive individuals.
• HIVAN presents with collapsing focal segmental glomerulosclerosis, podocyte proliferation, tubule microcystic dilatation, and interstitial nephritis.
• Patients typically exhibit advanced HIV-1 infection, renal insufficiency, and significant proteinuria.

Purpose of the Study:

• To review the pathogenesis and management of HIV-associated nephropathy (HIVAN).
• To highlight the diagnostic challenges and the importance of renal biopsy in HIVAN.
• To discuss the therapeutic efficacy of highly active antiretroviral therapy (HAART) and other treatments.

Main Methods:

• Literature review of studies on HIVAN pathogenesis and treatment.
• Analysis of clinical presentations and diagnostic criteria for HIVAN.
• Evaluation of the impact of HAART, ACE inhibitors, and prednisone on HIVAN outcomes.

Main Results:

• Viral infection of renal cells is central to HIVAN pathogenesis.
• Renal biopsy is crucial for diagnosing HIVAN due to the lack of specific serologic markers.
• Highly active antiretroviral therapy (HAART) demonstrates effectiveness in preventing end-stage renal disease in HIVAN patients.

Conclusions:

• HIVAN is a serious renal complication of HIV-1 infection requiring prompt diagnosis and management.
• HAART is a key therapeutic strategy for managing HIVAN and preventing its progression.
• Further prospective studies are needed to fully establish the efficacy of ACE inhibitors and prednisone in HIVAN treatment.